Veterinary Pharmaceuticals Market
完整報告名稱與涵蓋範圍
Veterinary Pharmaceuticals Market Size, Share & Trends Analysis Report, By Product Category (Parasiticides, Anti-Infectives, Vaccines, Pain, Anti-Inflammatory and Anesthesia, Chronic Disease and Specialty Therapeutics, Feed Additives and Medicated Premixes), By Animal Type (Companion Animals, Cattle and Ruminants, Swine, Poultry, Aquaculture and Other Species), By Route of Administration (Oral, Injectable, Topical and Other Routes), By Distribution Channel, By Region, and Segment Forecasts, 2026-2035
報告摘要
The veterinary pharmaceuticals market covers medicines, vaccines and medicated feed products for companion animals and livestock, including parasiticides, anti-infectives, vaccines, pain and anesthesia products, chronic disease and specialty therapeutics and feed additives, across oral, injectable and topical routes. Animal diagnostics, nutrition, veterinary services and companion animal medicine as a standalone category are addressed in separate studies; this study provides the all-species view.
Demand is supported by growing protein consumption that drives livestock health spending, by the humanisation of pets that expands companion animal therapeutics and by disease pressures such as avian influenza, African swine fever and antimicrobial resistance that reshape vaccine and anti-infective use. Regulators are restricting antibiotic growth promoters and prophylactic antibiotics, accelerating demand for vaccines, immunomodulators and alternatives, while biologics, long-acting formulations and precision dosing technologies migrate from human medicine. Generic competition, commodity price cycles in livestock and the consolidation of veterinary distribution shape pricing and channel dynamics.
North America and Europe lead value, and Asia Pacific and Latin America grow fastest on livestock intensification and pet ownership, with China and Brazil as major markets. Competition involves global animal health leaders, regional livestock specialists and generic manufacturers.
The InsightAce study supplies US$ forecasts for all product category, animal type, route of administration and distribution channel and regional segments over 2026-2035, segment-level trend analysis, competitive landscape assessment and profiling of the leading companies.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Veterinary Pharmaceuticals Market Snapshot
Chapter 4. Global Veterinary Pharmaceuticals Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Product Category Estimates & Trend Analysis
5.1. Product Category & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Product Category:
5.2.1. Parasiticides
5.2.2. Anti-Infectives
5.2.3. Vaccines
5.2.4. Pain, Anti-Inflammatory and Anesthesia
5.2.5. Chronic Disease and Specialty Therapeutics
5.2.6. Feed Additives and Medicated Premixes
Chapter 6. Market Segmentation 2: By Animal Type Estimates & Trend Analysis
6.1. Animal Type & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Animal Type:
6.2.1. Companion Animals
6.2.2. Cattle and Ruminants
6.2.3. Swine
6.2.4. Poultry
6.2.5. Aquaculture and Other Species
Chapter 7. Market Segmentation 3: By Route of Administration Estimates & Trend Analysis
7.1. Route of Administration & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Route of Administration:
7.2.1. Oral
7.2.2. Injectable
7.2.3. Topical and Other Routes
Chapter 8. Market Segmentation 4: By Distribution Channel Estimates & Trend Analysis
8.1. Distribution Channel & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Distribution Channel:
8.2.1. Veterinary Clinics and Hospitals
8.2.2. Distributors and Farm Supply
8.2.3. Retail and E-Commerce Pharmacies
Chapter 9. Veterinary Pharmaceuticals Market: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Southeast Asia
9.3.7. Rest of Asia Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. Zoetis Inc.
11.2. Merck Animal Health (MSD Animal Health)
11.3. Boehringer Ingelheim Animal Health
11.4. Elanco Animal Health Incorporated
11.5. Ceva Sante Animale
11.6. Virbac S.A.
11.7. Phibro Animal Health Corporation
11.8. Dechra Pharmaceuticals PLC
11.9. Vetoquinol S.A.
11.10. Huvepharma AD
11.11. Bimeda Holdings
11.12. Norbrook Laboratories Limited
11.13. Ourofino Saude Animal
11.14. Hipra S.A.
11.15. China Animal Husbandry Industry Co., Ltd.
圖表清單 List of Tables & Figures
Table 1. Global Veterinary Pharmaceuticals Revenue Forecast by Product Category, 2026-2035 (US$ Mn)
Figure 1. Global Veterinary Pharmaceuticals Market Snapshot, 2026 & 2035
Table 2. Global Veterinary Pharmaceuticals Revenue Forecast by Animal Type, 2026-2035 (US$ Mn)
Figure 2. Global Veterinary Pharmaceuticals Market Share by Animal Type, 2026 & 2035
Table 3. Global Veterinary Pharmaceuticals Revenue Forecast by Route of Administration, 2026-2035 (US$ Mn)
Figure 3. Veterinary Pharmaceutical Demand by Species and Product Category, 2026-2035
Table 4. Global Veterinary Pharmaceuticals Revenue Forecast by Distribution Channel, 2026-2035 (US$ Mn)
Figure 4. Antimicrobial Stewardship Regulation and the Shift Toward Vaccines and Alternatives
Table 5. North America Veterinary Pharmaceuticals Revenue by Country, 2026-2035 (US$ Mn)
Figure 5. Asia Pacific Veterinary Pharmaceuticals Growth Opportunity Analysis
Table 6. Europe Veterinary Pharmaceuticals Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Innovation Pipeline in Animal Health: Biologics, Long-Acting Formulations and Precision Dosing
Table 7. Asia Pacific Veterinary Pharmaceuticals Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Competitive Positioning of Key Veterinary Pharmaceuticals Market Participants
Table 8. Latin America and Middle East & Africa Veterinary Pharmaceuticals Revenue Forecast, 2026-2035 (US$ Mn)
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們